← Evidence map

ReviewHemaSphere2023

BCL2 Inhibition: A New Paradigm for the Treatment of AML and Beyond.

Andrew H Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37304937